The information is available through an interactive online platform, provided in the form of weekly updates sent by e-mail. It is possible to create pdf files with the latest news.
As part of your paid subscription to PMR Market Insight, you also receive a monthly comprehensive overview of data and analyses with the most important market statistics.
What is the content of PMR's Insight?
In the PMR weekly magazine you will find continuously updated information on the impact of coronavirus on the sector, including:
- Analyses of the current situation and development prospects in Poland and abroad in connection with the COVID-19 epidemic
- Forecasts and indicators that will affect the healthcare market in the coming months, based on data collected by PMR
- Articles describing strategic solutions and concepts used by industry leaders in response to the changes brought about by the epidemic
- Current and future trends, possible after the epidemic and key macroeconomic factors
- Articles showing the expected major events that may affect the healthcare industry.
- Expert commentaries given by industry leaders, association representatives, economists and PMR’s analysts
- Articles that offer strategic solutions and ideas from top market performers as well as industry and legal experts articles revealing pharmaceutical market developments, future prospects, emerging trends and important upcoming events that are expected to influence business conditions
- Commentaries and viewpoints from external and internal specialists
And also:
- PMR research results combined with explanations by PMR experts
- Analysis of financial results of selected market players active in the segments of private healthcare, medical devices, drug distributors, drug manufacturers
- Analyses of the most important mergers and acquisitions transactions influencing the pharma and healthcare market in Poland
- Legislative changes, the reactions of industry and patient associations
- Healthcare policy developments with regard to reimbursements and pricing of drugs and patient services
- National Health Fund, Health Ministry and other governmental actions influencing pharma and healthcare markets
- Health Technology Assessment Agency recommendations on approval of new medicines and therapies for reimbursement, levels of and conditions required for reimbursement, changes to the list of approved medications
- Activities of pharmaceutical companies, including major manufacturers and distributors in the areas of wholesale pharmacy and retail chains – their collaborations, new drug registrations, market plans and strategies, financial results
- Coverage of the research and development (R&D) sector including new project and young company watch insights
- Public and private healthcare market structure news and analyses, with data on the size of the market, forecasts and number of healthcare facilities based on unique PMR methodology, and local and international investors
- Epidemiology reports
- A wide range of macroeconomic and industry-related statistics, data, indicators and dashboardsArchive of articles and data for the sector.